Edition:
United Kingdom

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

25.03USD
16 Feb 2018
Change (% chg)

$-0.57 (-2.23%)
Prev Close
$25.60
Open
$25.47
Day's High
$26.53
Day's Low
$25.02
Volume
160,215
Avg. Vol
297,203
52-wk High
$33.20
52-wk Low
$11.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 5.92 -0.447
Mar '17 6.22 -0.364
FY 2016 Dec '16 5.63 -0.305
Sep '16 4.87 -0.218
Jun '16 4.21 -0.361
Mar '16 1.78 -0.191
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 6.25 7.50 5.00 --
Quarter Ending Jun-18 2 6.45 7.90 5.00 --
Year Ending Dec-18 5 32.29 42.00 23.70 40.67
Earnings (per share)
Quarter Ending Mar-18 2 -0.54 -0.52 -0.55 --
Quarter Ending Jun-18 2 -0.57 -0.57 -0.58 --
Year Ending Dec-18 5 -2.08 -1.52 -2.64 -0.98
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 49.36 110.72 5.77
Price to Book (MRQ) 5.95 13.56 5.41
Price to Tangible Book (MRQ) 5.95 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 47.11 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 40.68 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago 141.65 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -23.76 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago -69.49 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 9.33 5.30 2.97
LT Debt to Equity (MRQ) 0.00 22.82 12.22
Total Debt to Equity (MRQ) 0.00 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -200.83 -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -209.85 -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -204.48 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -204.48 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 217,577 22,602,121 855,667,832
Net Income/Employee (TTM) -444,894 2,968,747 100,655,557
Receivable Turnover (TTM) 12.02 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.08 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -16.08 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -17.54 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -22.51 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 172.65 -- --
EPS (TTM) % -303.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Intellia Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 39.32 34.52 99 53
13 Week 86.55 77.47 99 62
26 Week 126.26 109.06 99 77
52 Week 87.00 58.50 99 50
YTD 135.93 107.19 99 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 58.56%
# of Holders: 163
Total Shares Held: 24,792,512
3 Mo. Net Change: 7,218,444
# New Positions: 46
# Closed Positions: 17
# Increased Positions: 101
# Reduced Positions: 34
# Net Buyers: 67
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.